Literature DB >> 30345460

Relative Telomere Length and Stroke Risk in a Chinese Han Population.

Dan Gao1, Rui Zhang1, Guofa Ji1, Chunqi Li2, Dangshe Guo2, Tianbo Jin3, Mingwei Chen4.   

Abstract

This study aimed to further understand the role of relative telomere length (RTL) in susceptibility to stroke and investigate the association regulator of telomere elongation helicase 1 (RETL1) gene polymorphisms and RTL. RTL was measured using the real-time quantitative polymerase chain reaction (qPCR) from 300 stroke patients and 299 healthy controls. Genotyping was performed using the Sequenom MassARRAY platform. The results indicated that stroke patients had significantly shorter median RTL than controls (P < 0.001). Compared with the longer RTL (≥ 0.766), the shorter RTL (< 0.766) was significantly increased the risk of stroke (odds ratio [OR] = 8.44, 95% confidence interval [CI] 5.42-13.14, P < 0.001). The RTL was categorized into tertiles, we found that the shorter RTL (0.515-1.366) (OR = 16.27, 95% CI 7.72-34.29, P < 0.001) and lowest RTL (< 0.515) (OR = 30.63, 95% CI 14.27-65.75, P < 0.001) were significantly increased stroke risk compared with the highest RTL (> 1.366). Stratified analysis showed that the shorter RTL was also significantly increased the risk of stroke compared with the longer RTL in male, age < 60 years and ≥ 60 years, except the female participants. In addition, individuals with the genotypes AA (rs2297441) and GG (rs6089953) have shorter telomeres than the genotypes GG (P = 0.031) and AA (P = 0.032), respectively. Our results suggested that shorter RTL was associated with an increased risk of stroke. The association was found between the genotypes AA (rs2297441) and GG (rs6089953) and shorter RTL in case group. Further studies in larger sample size and biological functional assays are warranted to validate our findings.

Entities:  

Keywords:  Chinese Han; RTEL1 polymorphisms; Relative telomere length; Stroke

Mesh:

Substances:

Year:  2018        PMID: 30345460     DOI: 10.1007/s12031-018-1160-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

Review 1.  Epidemiology and prevention of stroke: a worldwide perspective.

Authors:  Elena V Kuklina; Xin Tong; Mary G George; Pooja Bansil
Journal:  Expert Rev Neurother       Date:  2012-02       Impact factor: 4.618

2.  Telomere length and risk of stroke in Chinese.

Authors:  Hu Ding; Chen Chen; John R Shaffer; Lei Liu; Yujun Xu; Xiaojing Wang; Rutai Hui; Dao Wen Wang
Journal:  Stroke       Date:  2012-02-16       Impact factor: 7.914

Review 3.  Telomeres and telomerase: the means to the end (Nobel lecture).

Authors:  Elizabeth H Blackburn
Journal:  Angew Chem Int Ed Engl       Date:  2010-10-04       Impact factor: 15.336

4.  Leukocyte telomere length and mortality in the Cardiovascular Health Study.

Authors:  Annette L Fitzpatrick; Richard A Kronmal; Masayuki Kimura; Jeffrey P Gardner; Bruce M Psaty; Nancy S Jenny; Russell P Tracy; Sheetal Hardikar; Abraham Aviv
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-02-02       Impact factor: 6.053

Review 5.  Telomere length inheritance and aging.

Authors:  Dennis Kappei; J Arturo Londoño-Vallejo
Journal:  Mech Ageing Dev       Date:  2007-10-30       Impact factor: 5.432

Review 6.  Stroke and stroke care in China: huge burden, significant workload, and a national priority.

Authors:  Liping Liu; David Wang; K S Lawrence Wong; Yongjun Wang
Journal:  Stroke       Date:  2011-11-03       Impact factor: 7.914

Review 7.  Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection.

Authors:  Elizabeth H Blackburn; Elissa S Epel; Jue Lin
Journal:  Science       Date:  2015-12-04       Impact factor: 47.728

Review 8.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

9.  RTEL1 maintains genomic stability by suppressing homologous recombination.

Authors:  Louise J Barber; Jillian L Youds; Jordan D Ward; Michael J McIlwraith; Nigel J O'Neil; Mark I R Petalcorin; Julie S Martin; Spencer J Collis; Sharon B Cantor; Melissa Auclair; Heidi Tissenbaum; Stephen C West; Ann M Rose; Simon J Boulton
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

10.  Association between regulator of telomere elongation helicase1 (RTEL1) gene and HAPE risk: A case-control study.

Authors:  Hao Rong; Xue He; Linhao Zhu; Xikai Zhu; Longli Kang; Li Wang; Yongjun He; Dongya Yuan; Tianbo Jin
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

View more
  2 in total

1.  Telomerase activation in the treatment of aging or degenerative diseases: a systematic review.

Authors:  P Prieto-Oliveira
Journal:  Mol Cell Biochem       Date:  2020-10-01       Impact factor: 3.396

2.  Association between telomere length in peripheral blood leukocytes and risk of ischemic stroke in a Han Chinese population: a linear and non-linear Mendelian randomization analysis.

Authors:  Weijie Cao; Deqiang Zheng; Jie Zhang; Anxin Wang; Di Liu; Jinxia Zhang; Manjot Singh; Isinta Elijah Maranga; Mingyang Cao; Lijuan Wu; Manshu Song; Wei Wang; Youxin Wang
Journal:  J Transl Med       Date:  2020-10-12       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.